Retinoids Control the Expression of c-erbB Receptors in Breast Cancer Cells
- 29 October 1998
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 251 (3), 907-913
- https://doi.org/10.1006/bbrc.1998.9570
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- An intron 1 enhancer element mediates oestrogen-induced suppression of ERBB2 expressionOncogene, 1997
- Tyrosine kinase signaling pathways control the expression of retinoic acid receptor-α in SK-BR-3 breast cancer cellsCancer Letters, 1997
- Bidirectional interactions between the estrogen receptor and the c‐erbB‐2 signaling pathways: Heregulin inhibits estrogenic effects in breast cancer cellsInternational Journal of Cancer, 1995
- Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl.The Journal of Experimental Medicine, 1995
- Tyrosine Kinase Inhibition: An Approach to Drug DevelopmentScience, 1995
- Retinoic Acid Inhibition of Insulin-like Growth Factor I Stimulation of c-fos mRNA Levels in a Breast Carcinoma Cell LineExperimental Cell Research, 1994
- The Family of c-erbB Genes: From Basic Research to Clinical OncologyOncology Research and Treatment, 1994
- Ligand-activated thyroid hormone and retinoic acid receptors inhibit growth factor receptor promoter expressionCell, 1990
- Differentiation of cultured human breast cancer cells (AU‐565 and MCF‐7) associated with loss of cell surface HER‐2/neu antigenMolecular Carcinogenesis, 1990
- The neu oncogene encodes an epidermal growth factor receptor-related proteinNature, 1986